Karyn Aalami Goodman was named associate director for clinical research at Mount Sinai’s The Tisch Cancer Institute. She is also professor and vice chair for research and quality in the Department of Radiation Oncology.
As the Galleri test is advancing toward becoming the first multi-cancer detection test to secure FDA approval, cancer care providers are coming up with strategies for using these tests responsibly.
